We then evaluated the expression of SH3BP2 and MITF in other GIST cell lines, including imatinib‐sensitive GIST‐T1 and different imatinib‐resistant sublines derived from GIST‐T1 and GIST430/654 cells. This evidence concerns the gene SH3BP2 and gastrointestinal stromal tumor.